Maxx Chatsko Articles

•   RSS Feed
• View Profile

Last 50 articles...

• 50 Billion Reasons to Support Ethanol
• 25 Belt-Busting Obesity Facts
• 5 Best Stocks to Invest in Industrial Biotech
• 4 Foolish Things I Learned From "American Greed"
• 2 Red Flags for Merck's Type 2 Diabetes Blockbuster
• Terra Nitrogen Is Set to Cruise With Higher Nutrient Prices
• Agrium Doesn't Believe in an Off-Season
• CF Industries Bets on the Right Side of Natural Gas Prices
• Don't Get Too Excited About This Cancer Drug Yet
• Can Allergy Season Make You Rich?
• 1 Thing Investors Overlooked in Solazyme's Breakthrough
• Big Pharma's Biggest Losers
• Big Pharma's Biggest Winners
• Will Investors Take the Plunge Over the Patent Cliff With Humira?
• This Bill Wants to Cut Ethanol Production in Half
• Solazyme Adds (More) Precision to Tailored Oil Platform
• Is the Golden Age of Blockbusters Over?
• This Biotech Stock Keeps Investors Patiently Waiting
• 3 Hallmarks of a Megablockbuster
• Is the Biggest Pharma Company in the World the Best Investment?
• REG Earnings Get a Boost From Fuel Credits
• Don't Try to Pick the Best Biotech Company
• 3 Biotech Companies for Young Investors
• 1 Fertilizer Stock to Buy When Natural Gas Prices Rise
• Can Johnson Controls Stock Shake off European Worries?
• Is Southern Company Stock Too Hot to Touch?
• Will Natural Gas Prices Tank Consolidated Edison Stock?
• Yawn Your Way to Retirement With Abbott Laboratories Stock
• Ferocious Beetles Destroy Forests and Hurt Homebuilders
• Are These 4 Stocks Still Cheap Investments?
• Is Amgen Stock Too Hot to Touch?
• Merck Stock Isn't Worth It
• This Blow to Malaria Is No News for Investors
• Will the FDA Wake Up to This Drug's Potential?
• Can Merck Field a Psoriasis Blockbuster?
• 2 Ways Cleaner Gasoline Will Help Refiners
• Solazyme Management Is a Step Ahead
• Is Shell Making a Sequel to "Waterworld"?
• Can These Companies Prove Big Oil Wrong?
• Can America Blow Away Nuclear Power?
• Why Big Oil Is Ditching Biotechnology
• These Blockbusters Have Different Futures for Merck
• Is Merck's Type 2 Diabetes Blockbuster in Trouble?
• General Electric's Answer for Radioactive Zombies
• Make an Investment in Your Grandchildren's Future
• Johnson & Johnson Invokana PDUFA Preview
• Will Soaring Ethanol Credits Cost You at the Pump?
• 8 Projects Bringing Synthetic Biology to Your Doorstep
• Will Testosterone Fuel Biotech's Next Great Race?
• Codexis Eyes Raizen With Latest Enzymes